Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphomaAndrea Rinaldi, Francesco Bertoni, Ivo Kwee et al.|British Journal of Haematology|2005Cited by 193
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcomeMaria Grazia Tibiletti, Francesco Bertoni, Barbara Del Curto et al.|Human Pathology|2009Cited by 109
ALK Testing in Lung Adenocarcinoma: Technical Aspects to Improve FISH Evaluation in Daily PracticeVittoria Martin, Maria Grazia Tibiletti, Barbara Bernasconi et al.|Journal of Thoracic Oncology|2014Cited by 51
EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical EffectNora Sahnane, Vittoria Martin, Milo Frattini et al.|Clinical Lung Cancer|2015Cited by 37
Cyclin-dependent kinase inhibitor seliciclib shows<i>in vitro</i>activity in diffuse large B-cell lymphomasKatia Lacrima, Francesco Bertoni, Andrea Rinaldi et al.|Leukemia & lymphoma/Leukemia and lymphoma|2007Cited by 22